PD‐L1/PD‐L1 signalling promotes colorectal cancer cell migration ability through RAS/MEK/ERK

Programmed death ligand 1 (PD‐L1) is widely known as an immune checkpoint, and immunotherapy through the inhibition of checkpoint molecules has become an important component in the successful treatment of tumours via programmed death 1 (PD‐1)/PD‐L1 signalling pathways. However, its biological functi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Yihui, Liang, Weiye, Fang, Lian, Liu, Ming‐kai, Zuo, Jia, Peng, Ying‐long, Shan, Jia‐jie, Sun, Rui‐xia, Zhao, Jie, Wang, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826327/
https://www.ncbi.nlm.nih.gov/pubmed/36050267
http://dx.doi.org/10.1111/1440-1681.13717

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9826327/
https://www.ncbi.nlm.nih.gov/pubmed/36050267
http://dx.doi.org/10.1111/1440-1681.13717

Ejemplares similares